Bentham Science Logo

Contents

Current Drug Discovery Technologies, Volume 4 - Number 1

Activity-Based Proteomics of Lipolytic Enzymes

, 4(1): 1 - 11

Ruth Birner-Gruenberger and Albin Hermetter


DOI: 10.2174/157016307781115458




Microarray Analysis Reveals CCL24/Eotaxin-2 as an Effector of the Pathogenetic Effects Induced by HIV-1 Nef

, 4(1): 12 - 23

Gianna Fiorucci, Eleonora Olivetta, Maria Vincenza Chiantore and Maurizio Federico


DOI: 10.2174/157016307781115502




Transcription Factor Profiling Shows New Ways Towards New Treatment Options of Cutaneous T cell lymphomas

, 4(1): 24 - 30

Udo Dobbeling


DOI: 10.2174/157016307781115467




Controlled Release of the Pineal Hormone Melatonin from Hydroxypropylmethylcellulose/Sodium Alginate Matrices in Aqueous Media Containing Dioctyl Sulfosuccinate

, 4(1): 31 - 38

Marilena Vlachou, Athanasia Tsiakoulia and Aphrodite Eikosipentaki


DOI: 10.2174/157016307781115449




Diabetes Beyond Insulin: Review of New Drugs for Treatment of Diabetes Mellitus

, 4(1): 39 - 47

Pankaj Modi


DOI: 10.2174/157016307781115476




Targetability of Human Disease Genes

, 4(1): 48 - 58

Meena K. Sakharkar and Kishore R. Sakharkar


DOI: 10.2174/157016307781115494




Pharmacogenomics of Sex Difference in Chemotherapeutic Toxicity

, 4(1): 59 - 68

Jeffrey Wang and Ying Huang


DOI: 10.2174/157016307781115485




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science